Alpha Tau Medical Cash Flow from Financial Activities 2020-2025 | DRTS

Alpha Tau Medical cash flow from financial activities from 2020 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities

Alpha Tau Medical Cash Flow from Financial Activities 2020-2025 | DRTS

Alpha Tau Medical cash flow from financial activities from 2020 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$182B
Intuitive Surgical (ISRG)$178.1B
Edwards Lifesciences (EW)$47.2B
IDEXX Laboratories (IDXX)$46.1B
Alcon (ALC)$45.1B
DexCom (DXCM)$35B
IQVIA Holdings (IQV)$33.1B
Mettler-Toledo (MTD)$26.3B
STERIS (STE)$22.5B
Waters (WAT)$18B
SONOVA HOLDING (SONVY)$17.2B
Hologic (HOLX)$14.7B
Sysmex ADR (SSMXY)$10.6B
Penumbra (PEN)$8.8B
Masimo (MASI)$8.6B
Globus Medical (GMED)$7.3B
Glaukos (GKOS)$5.4B
Teleflex (TFX)$5.1B
Integer Holdings (ITGR)$3.8B
TransMedics (TMDX)$3.5B
PROCEPT BioRobotics (PRCT)$3B
LivaNova (LIVN)$2.4B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.9B
Veracyte (VCYT)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Tandem Diabetes Care (TNDM)$1.1B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B